Clinician reported ease of use for a novel fibrin sealant patch for hemostasis: Results from four randomized controlled trials

Current Medical Research and Opinion

Volumn 32, Issue 2, 2016, Pages 367-376

  Corral, M ^a   Ferko, N ^b   Hollmann, S ^b   Hogan, A ^b   Jamous, N ^a   Batiller, J ^a   Shen, J ^a  

^a ETHICON INC   (United States)

^b Department of Data Analytics and Evidence Synthesis   (Canada)

Author keywords

Bleeding; Fibrin sealant; Hemostatics; Questionnaire; Surgery

Indexed keywords

FIBRIN GLUE; OXIDIZED REGENERATED CELLULOSE; HEMOSTATIC AGENT;

ADULT; AGED; ARTICLE; BLEEDING; CLINICAL EVALUATION; CONTROLLED STUDY; EASE OF USE; EASE OF USE QUESTIONNAIRE; FEMALE; HEALTH CARE QUALITY; HEMOSTASIS; HUMAN; LIVER HEMORRHAGE; MALE; META ANALYSIS; OPERATIVE BLOOD LOSS; PATIENT SATISFACTION; PRODUCT PARAMETERS; QUALITY OF LIFE ASSESSMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); SOFT TISSUE BLEEDING; SOFT TISSUE DISEASE; BLOOD LOSS, SURGICAL; QUESTIONNAIRE; TRANSDERMAL PATCH;

BLOOD LOSS, SURGICAL; FIBRIN TISSUE ADHESIVE; HEMOSTASIS; HEMOSTATICS; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SURVEYS AND QUESTIONNAIRES; TRANSDERMAL PATCH;

EID: 84955198910     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2015.1128405     Document Type: Article

References (40)

1. Boucher BA, Traub O. Achieving hemostasis in the surgical field. Pharmacotherapy 2009;29:2-7s
2. Stokes ME, Ye X, Shah M, et al. Impact of bleeding-related complications and/or blood product transfusions on hospital costs in inpatient surgical patients. BMC Health Serv Res 2011;11:135
3. Marietta M, Pedrazzi P, Girardis M, Luppi M. Massive bleeding: are we doing our best? Transfus Apher Sci 2011;45:287-90
4. Marietta M, Facchini L, Pedrazzi P, et al. Pathophysiology of bleeding in surgery. Transplant Proc 2006;38:812-14
5. Vera-Llonch M, Hagiwara M, Oster G. Clinical and economic consequences of bleeding following major orthopedic surgery. Thromb Res 2006;117:569-77
6. Wu WC, Trivedi A, Friedmann PD, et al. Association between hospital intraoperative blood transfusion practices for surgical blood loss and hospital surgical mortality rates. Ann Surg 2012;255:708-14
7. Karkouti K, Wijeysundera DN, Yau TM, et al. The independent association of massive blood loss with mortality in cardiac surgery. Transfusion 2004;44:1453-62
8. Koea JB, Batiller J, Patel B, et al. A phase III, randomized, controlled, superiority trial evaluating the fibrin pad versus standard of care in controlling parenchymal bleeding during elective hepatic surgery. HPB 2013;15:61-70
9. Fischer CP, Bochicchio G, Shen J, et al. A prospective, randomized, controlled trial of the efficacy and safety of fibrin pad as an adjunct to control soft tissue bleeding during abdominal, retroperitoneal, pelvic, and thoracic surgery. J Am Coll Surg 2013;217:385-93
10. Koea J, Baldwin P, Shen J, et al. Safety and hemostatic effectiveness of the fibrin pad for severe soft-tissue bleeding during abdominal, retroperitoneal, pelvic, and thoracic (non-cardiac) surgery: a randomized, controlled, superiority trial. World J Surg 2015; 39(11):2663-9
11. Samudrala S. Topical hemostatic agents in surgery: a surgeon's perspective. AORN J 2008;88:S2-11
12. Spotnitz WD, Burks S. Hemostats, sealants, and adhesives: components of the surgical toolbox. Transfusion 2008;48:1502-16
13. Rossaint R, Bouillon B, Cerny V, et al; Task Force for Advanced Bleeding Care in Trauma. Management of bleeding following major trauma: an updated European guideline. Crit Care 2010;14:R52
14. Vyas KS, Saha SP. Comparison of hemostatic agents used in vascular surgery. Expert Opin Biol Ther 2013;13:1663-72
15. Wang GJ, Goldthwaite Jr. CA, Burks SG, Spotnitz WD; Orthopaedic Research Group. Experience improves successful use of fibrin sealant in total knee arthroplasty: implications for surgical education. J Long Term Eff Med Implants 2003;13:389-97
16. Zacher J, Schattenkirchner M. Patient and physician satisfaction with rofecoxib in osteoarthritis: results of a post-marketing surveillance study in primary care in Germany. Curr Med Res Opin 2002;18:229-36
17. Mathiasen RA, Cruz RM. Prospective, randomized, controlled clinical trial of a novel matrix hemostatic sealant in patients with acute anterior epistaxis. Laryngoscope 2005;115:899-902
18. Bohannon NJ, Ohannesian JP, Burdan AL, et al. Patient and physician satisfaction with the Humulin/Humalog Pen, a new 3.0-mL prefilled pen device for insulin delivery. Clin Therapeut 2000;22:1049-67
19. Ethicon, Inc. EVARREST Prescribing Information. 2012. Somerville, NJ, USA
20. Data on file (unpublished). A phase III randomized, controlled, superiority study evaluating Evarrest Fibrin Sealant Patch versus standard of care treatment in controlling parenchymal bleeding during hepatic surgery. Clinical summary report BIOS-13-005 (NCT01993888). November 13, 2014
21. Evans BE, Irving SP, Aledort LM. Use of microcrystalline collagen for hemostasis after oral surgery in a hemophiliac. J Oral Surg (American Dental Association: 1965) 1979;37:126-8
22. Aaronson N, Alonso J, Burnam A, et al. Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res 2002;11:193-205
23. Health USDo, Human Services FDACfDE, Research, Health USDo, Human Services FDACfBE et al. (2006) Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes 4: 79
24. Arboleya LR, de la Figuera E, Soledad Garcia M, Aragon B. Experience of rofecoxib in patients with osteoarthritis previously treated with traditional nonsteroidal anti-inflammatory drugs in Spain: results of phase 2 of the VICOXX study. Curr Med Res Opin 2003;19:288-97
25. Kaufman CS, Littrup PJ, Freeman-Gibb LA, et al. Office-based cryoablation of breast fibroadenomas with long-term follow-up. Breast J 2005;11:344-50
26. Steinfeld S, Poriau S. Patient and physician satisfaction with rofecoxib in osteoarthritis: results of the EVA (experience with VIOXX in arthritis) survey. Curr Med Res Opin 2001;17:81-7
27. Weiss M, Vered I, Foldes AJ, et al. Treatment preference and tolerability with alendronate once weekly over a 3-month period: an Israeli multi-center study. Aging Clin Exp Res 2005;17:143-9
28. Spotnitz WD, Burks S. State-of-the-art review: hemostats, sealants, and adhesives II: update as well as how and when to use the components of the surgical toolbox. Clin Appl Thromb Hemost 2010;16:497-514
29. Feuerbacher RL, Funk KH, Spight DH, et al. Realistic distractions and interruptions that impair simulated surgical performance by novice surgeons. Arch Surg (Chicago, Ill: 1960) 2012;147:1026-30
30. Wiegmann DA, ElBardissi AW, Dearani JA, et al. Disruptions in surgical flow and their relationship to surgical errors: an exploratory investigation. Surgery 2007;142:658-65
31. McDonald J, Orlick T, Letts M. Mental readiness in surgeons and its links to performance excellence in surgery. J Pediatr Orthop 1995;15:691-7
32. Carthey J, de Leval MR, Reason JT. The human factor in cardiac surgery: errors and near misses in a high technology medical domain. Ann Thorac Surg 2001;72:300-5
33. Carthey J, de Leval MR, Wright DJ, et al. Behavioural markers of surgical excellence. Safety Science 2003;41:409-25
34. de Leval MR, Carthey J, Wright DJ, et al. Human factors and cardiac surgery: a multicenter study. J Thorac Cardiovasc Surg 2000;119:661-72
35. Healey AN, Sevdalis N, Vincent CA. Measuring intra-operative interference from distraction and interruption observed in the operating theatre. Ergonomics 2006;49:589-604
36. Hildenbrand T. A new gelatine-based hemostat for sinonasal surgery: a clinical survey. In Vivo (Athens, Greece) 2013;27:523-6
37. Haas S. The use of a surgical patch coated with human coagulation factors in surgical routine: a multicenter postauthorization surveillance. Clin Appl Thromb Hemost 2006;12:445-50
38. Mathiasen RA, Cruz RM. Prospective, randomized, controlled clinical trial of a novel matrix hemostatic sealant in children undergoing adenoidectomy. Otolaryngology Head Neck Surg 2004;131:601-5
39. Qerimi B, Baumann P, Husing J, et al. Collagen hemostat significantly reduces time to hemostasis compared with cellulose: COBBANA, a single-center, randomized trial. Am J Surg 2013;205:636-41
40. Sielaff M, Hermanns M, Uhlig R, et al. Early experience with a novel gelatinebased sponge for local haemostasis in thyroid surgery. In Vivo (Athens, Greece) 2014;28:255-8